Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04486755
Phase: Phase 1
Trial Summary: A phase I trial to determine the safety of delivering three sequentially shorter RT schedules (20, 16, and 12 fractions) of HypoFx pelvic nodal RT in combination with a HypoFx, sim – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Maryland, Baltimore
Acronym:

Pin It on Pinterest